Attacks on publicly funded trials: what happens when industry does not want to know the answer

    loading  Checking for direct PDF access through Ovid

Abstract

In the second part of The BMJ investigation into struggles to use intravitreal bevacizumab, Deborah Cohen reveals the challenges facing those conducting publicly funded clinical trials

Related Topics

    loading  Loading Related Articles